Literature DB >> 31792352

Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.

Sean G W Driver1, Meremaihi R Jackson1, Konrad Richter2, Paul Tomlinson3, Ben Brockway4, Benjamin J Halliday1, David M Markie5, Stephen P Robertson6, Emma M Wade1.   

Abstract

Connective tissue disorders are a spectrum of diseases that affect the integrity of tissues including skin, vasculature, and joints. They are often caused by variants that disrupt genes encoding components of extracellular matrix (ECM). The fibulin glycoproteins are ECM proteins important for integrity of tissues including dermis, retina, fascia, and vasculature. The fibulin family consists of seven members (fibulins-1 to -7) and is defined by a fibulin-type domain at the C-terminus. The family is associated with human diseases, for instance a variant in FBLN1, encoding fibulin-1, is associated with synpolydactyly, while one in EFEMP1, encoding fibulin-3, causes Doyne honeycomb degeneration of the retina. Loss-of-function of fibulins-4 and -5 causes cutis laxa, while variants in fibulins-5 and -6 are associated with age-related macular degeneration. Of note, EFEMP1 is not currently associated with any connective tissue disorder. Here we show biallelic loss-of-function variants in EFEMP1 in an individual with multiple and recurrent abdominal and thoracic herniae, myopia, hypermobile joints, scoliosis, and thin translucent skin. Fibroblasts from this individual express significantly lower EFEMP1 transcript than age-matched control cells. A skin biopsy, visualised using light microscopy, showed normal structure and abundance of elastic fibres. The phenotype of this individual is remarkably similar to the Efemp1 knockout mouse model that displays multiple herniae with premature aging and scoliosis. We conclude that loss of EFEMP1 function in this individual is the cause of a connective tissue disorder with a novel combination of phenotypic features, and can perhaps explain similar, previously reported cases in the literature.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31792352      PMCID: PMC7080811          DOI: 10.1038/s41431-019-0546-7

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

1.  Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate.

Authors:  Aniket Mishra; Cécile Duplaà; Dina Vojinovic; Hideaki Suzuki; Muralidharan Sargurupremraj; Nuno R Zilhão; Shuo Li; Traci M Bartz; Xueqiu Jian; Wei Zhao; Edith Hofer; Katharina Wittfeld; Sarah E Harris; Sandra van der Auwera-Palitschka; Michelle Luciano; Joshua C Bis; Hieab H H Adams; Claudia L Satizabal; Rebecca F Gottesman; Piyush G Gampawar; Robin Bülow; Stefan Weiss; Miao Yu; Mark E Bastin; Oscar L Lopez; Meike W Vernooij; Alexa S Beiser; Uwe Völker; Tim Kacprowski; Aicha Soumare; Jennifer A Smith; David S Knopman; Zoe Morris; Yicheng Zhu; Jerome I Rotter; Carole Dufouil; Maria Valdés Hernández; Susana Muñoz Maniega; Mark Lathrop; Erik Boerwinkle; Reinhold Schmidt; Masafumi Ihara; Bernard Mazoyer; Qiong Yang; Anne Joutel; Elizabeth Tournier-Lasserve; Lenore J Launer; Ian J Deary; Thomas H Mosley; Philippe Amouyel; Charles S DeCarli; Bruce M Psaty; Christophe Tzourio; Sharon L R Kardia; Hans J Grabe; Alexander Teumer; Cornelia M van Duijn; Helena Schmidt; Joanna M Wardlaw; M Arfan Ikram; Myriam Fornage; Vilmundur Gudnason; Sudha Seshadri; Paul M Matthews; William T Longstreth; Thierry Couffinhal; Stephanie Debette
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

Review 2.  IMI 2021 Yearly Digest.

Authors:  Monica Jong; Jost B Jonas; James S Wolffsohn; David A Berntsen; Pauline Cho; Danielle Clarkson-Townsend; Daniel I Flitcroft; Kate L Gifford; Annechien E G Haarman; Machelle T Pardue; Kathryn Richdale; Padmaja Sankaridurg; Milly S Tedja; Christine F Wildsoet; Joan E Bailey-Wilson; Jeremy A Guggenheim; Christopher J Hammond; Jaakko Kaprio; Stuart MacGregor; David A Mackey; Anthony M Musolf; Caroline C W Klaver; Virginie J M Verhoeven; Veronique Vitart; Earl L Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-04-28       Impact factor: 4.799

3.  TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease.

Authors:  Bryan T MacDonald; Hasmik Keshishian; Charles C Mundorff; Alessandro Arduini; Daniel Lai; Kayla Bendinelli; Nicholas R Popp; Bidur Bhandary; Karl R Clauser; Harrison Specht; Nadine H Elowe; Dylan Laprise; Yi Xing; Virendar K Kaushik; Steven A Carr; Patrick T Ellinor
Journal:  Mol Cell Proteomics       Date:  2022-03-11       Impact factor: 7.381

4.  Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity.

Authors:  Steffi Daniel; Marian Renwick; Viet Q Chau; Shyamtanu Datta; Prabhavathi Maddineni; Gulab Zode; Emma M Wade; Stephen P Robertson; W Matthew Petroll; John D Hulleman
Journal:  J Mol Med (Berl)       Date:  2020-09-22       Impact factor: 4.599

5.  First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.

Authors:  Inger Norlyk Sheyanth; Ihab Bishara Lolas; Henrik Okkels; Ligor Pradeep Kiruparajan; Søren Kromann Abildgaard; Michael Bjørn Petersen
Journal:  Mol Genet Genomic Med       Date:  2021-03-10       Impact factor: 2.183

6.  Loss-of-Function Variants in EFEMP1 Cause a Recognizable Connective Tissue Disorder Characterized by Cutis Laxa and Multiple Herniations.

Authors:  Maxim Verlee; Aude Beyens; Alper Gezdirici; Elif Yilmaz Gulec; Lore Pottie; Silke De Feyter; Michiel Vanhooydonck; Piyanoot Tapaneeyaphan; Sofie Symoens; Bert Callewaert
Journal:  Genes (Basel)       Date:  2021-03-31       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.